Evidence map›Paper›PMID 41098963›Full record

ArticleIDCases2025

Neurobrucellosis manifesting as secondary hemiparkinsonism in a veterinary technician: A case report and evidence-based review.

José Daniel Sanchez, Paola Andrea Salazar Figueroa, Maria Paula Salazar Figueroa, Hanny Alejandra Corvalan Reinthaller

Abstract readCase Reports
In one paragraph

Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The microbiota-proteostasis axis: implications in neurodegenerative diseases.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

José Daniel SanchezUniversidad Tecnológica Indoamérica, Facultad de Ciencias de la Salud y Bienestar Humano, Quito, Ecuador.
Paola Andrea Salazar FigueroaUniversidad Tecnológica Indoamérica, Facultad de Ciencias de la Salud y Bienestar Humano, Quito, Ecuador.
Maria Paula Salazar FigueroaUniversidad Tecnológica Indoamérica, Facultad de Ciencias de la Salud y Bienestar Humano, Quito, Ecuador.
Hanny Alejandra Corvalan ReinthallerUniversidad Tecnológica Equinoccial, Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neurobrucellosis is a severe complication of brucellosis, occurring in 3%-10% of systemic cases. Movement disorders, particularly parkinsonism, are rare manifestations that present significant diagnostic challenges and are often associated with occupational exposure. Case Presentation: We report the case of a 51-year-old male veterinary technician who developed progressive right hemiparkinsonism over two years, accompanied by systemic symptoms including fever, weight loss, and arthralgia. Diagnosis was established through characteristic cerebrospinal fluid (CSF) findings of lymphocytic pleocytosis, positive CSF and serum serology for Conclusions: This case highlights neurobrucellosis as a critical differential diagnosis for atypical parkinsonism, particularly in patients with a relevant occupational or environmental exposure history. Early diagnosis through comprehensive serological and molecular testing, followed by prompt initiation of evidence-based antibiotic protocols, can substantially improve clinical outcomes. This report underscores the imperative of stringent occupational safety measures in preventing this debilitating zoonotic infection.

Indexed as

Case reportCeftriaxoneMovement disordersNeurobrucellosisOccupational exposureParkinsonismZoonotic disease

Identifiers

PMID41098963
PMCPMC12519177

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.